Our mission is to use state of the art technology to eliminate the morbidity and mortality caused by the global tobacco pandemic

Team IntelliQuit consists of experts in medicine and biochemistry, computer vision, artificial intelligence, mobile app development, marketing and business operations. Our CEO has been a thought leader in tobacco treatment for over 3 decades.
The mission of IntelliQuit™ is using state of the art technology to eliminate the morbidity and mortality caused by the global tobacco pandemic, increasing value for our customers and clinical partners.

Experts in medicine and biochemistry, computer vision, artificial intelligence.

 
 
Team IntelliQuit consists of experts in medicine and biochemistry, computer vision, artificial intelligence, mobile app development, marketing and business operations. Our CEO has been a thought leader in tobacco treatment for over 3 decades. Since September 11, 2001, he has been the Director of Tobacco Treatment for the Fire Department of the City of New York (FDNY) and may have treated more tobacco dependent individuals than anyone else in the United States. Since September 2001, FDNY tobacco prevalence has been reduced from 28% to less than 4 percent, with a biochemically confirmed quit rate of ~70% at 10-year follow-up.
Our CEO is also on the editorial boards of the Journal of Smoking Cessation and the Journal of Medical Internet Research. Our Medical Director is a board-certified pulmonologist and critical care specialist with decades of experience treating the tobacco dependent.

Frequently Asked
Questions

Measurement of urinary nicotine metabolites is the single most effective method for quantifying nicotine and tobacco consumption. Counting cigarettes, vaping sessions, or pouches, etc. has been found to be inadequate and biochemically inaccurate. Biochemical measurement of nicotine consumption can ensure accurate titration of tobacco treatment medications and clinical success. Our staff is always here to help you and your patients.
Yes. If the test is ordered and performed by licensed health care providers (HCPs). Insurance payments vary by insurance carrier, policy & geography. The national average reimbursement to licensed HCPs is over $100.00
The IntelliQuit Mobile App is available here at the Apple App Store. The IntelliQuit Mobile App supports the iPhone 5 or later with an iOS of 10.1 or later. Health Care providers with an Android device can have their tobacco-dependent patients upload their test results atMyNicotineTest.com
No. If you can take a smartphone picture, you can run the nicotine test. Our app correctly guides the user's smartphone into position.
If you are testing in an area with spotty or no internet connection you can save the image and upload the photo at a later time when an internet connection is stable.
Nicotine from all types of tobacco breaks-down in the human body and is eliminated in urine. These nicotine metabolites produce a shade of reddish-pink on the Nicotine Test Strip that depends on the amount of nicotine metabolites. The more nicotine metabolites present, the darker the reddish-pink color. This color is read by any smartphone camera and analyzed by our computer algorithm which relates that specific color to a specific level of nicotine metabolites. To calculate nicotine levels, we use sophisticated techniques such as computer vision, machine learning, and neural network architecture.
Many tobacco-using patients are not ready to stop smoking, vaping or chewing--And that's just fine! The IntelliQuit Nicotine Test measures nicotine consumption and will help guide you and your patients towards better health. Our tobacco treatment experts are here to help you help your patients towards better health.
The IntelliQuit tobacco treatment experts may have treated more tobacco users than anyone else in the United States, maybe the world. Team IntelliQuit would be happy to help any clinician with their tobacco-using patients.